SEC Form D · filed March 29, 2016
Orexigen Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Thomas Lynch · La Jolla, CAExecPatrick J. Mahaffy · La Jolla, CADirectorBrian H. Dovey · La Jolla, CADirectorMichael Narachi · La Jolla, CAExec · DirectorPreston Klassen · La Jolla, CAExecPeter K. Honig · La Jolla, CADirectorEckard S. Weber · La Jolla, CADirectorLouis C. Bock · La Jolla, CADirectorThomas Cannell · La Jolla, CAExecLota S. Zoth · La Jolla, CADirectorDavid J. Endicott · La Jolla, CADirectorMichael J. Gruber · Seattle, WADirectorGeorge Lobisser · Bainbridge Island, WAExecMaryrose N. Mallari · Bloomington, MNDirectorErnst-Guenter Afting · Los Altos, CAExecLeonardus H.T. Van Der Ploeg · Los Altos, CADirectorHeather Ace · La Jolla, CAExecPatrick J. Mckinney · Bloomington, MNExec · DirectorRobert P. Thorbus · Bloomington, MNDirectorReinhold P. Henke · Bloomington, MNDirectorJim Eberhard · Bozeman, MTExec · DirectorDavid Breck · Bozeman, MTDirectorDavid Sigler · Bozeman, MTExec · DirectorJohn F. Warnken-Brill · SAN FRANCISCO, CADirectorBrian F. Sheth · SAN FRANCISCO, CAExec · DirectorDaniela Taplin Lundberg · Westport, CTDirectorLawson D. Devries · Raleigh, NCExecPratima Sharma · Plano, TXExecHeather Ace · La Jolla, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗